Evidence 1
Activity
Activity
26% Hemolysis
Toxicity
100 µM
Hemolytic
Cytotoxic
26% Hemolysis | 100 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
A New Synthetic Peptide with In vitro Antibacterial Potential Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA). | Probiotics Antimicrob Proteins | 2016